Expression of the Sodium/Iodide Symporter in Human Prostate Adenocarcinoma

Urology

Volumn 75, Issue 4, 2010, Pages 773-778

  Navarra, Michele ^a   Micali, Salvatore ^b   Lepore, Saverio M ^c   Cesinaro, Anna Maria ^b   Celano, Marilena ^c   Sighinolfi, Maria C ^b   De Gaetani, Carmela ^b   Filetti, Sebastiano ^d   Bianchi, Giampaolo ^b   Russo, Diego ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; RNA; SODIUM IODIDE SYMPORTER;

AGED; ARTICLE; CORRELATION ANALYSIS; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; HUMANS; IODINE; MALE; PROSTATIC NEOPLASMS; SYMPORTERS;

EID: 77950300421     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.10.011     Document Type: Article

References (30)

1. Yin M., Bastaky S., Chandran U., et al. Prevalence of incidental prostate cancer in general population: a study of healthy organ donors. J Urol 179 (2008) 892-895
2. Heidenreich A., Bolla M., Joniau S., et al. Guidelines on Prostate Cancer, EAU Guidelines 2009 Edition. http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/Prostate_Cancer.pdf Accessed October 1, 2009
3. Polascik T.J., Oesterling J.E., and Partin A.W. Prostate specific antigen: a decade of discovery what we have learned and where we are going. J Urol 162 (1999) 293-306
4. Stamey T.A., Caldwell M., McNeal J.E., et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?. J Urol 172 4 Pt 1 (2004) 1297-1301
5. Dai G., Levy O., and Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 379 (1996) 458-460
6. Dohan O., De la Vieja A., Paroder V., et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24 (2003) 48-77
7. Spitzweg C., Joba W., Eisenmenger W., et al. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 83 (1998) 1746-1751
8. Lacroix L., Mian C., Caillou B., et al. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144 (2001) 297-302
9. Wapnir I.L., Van de Rijn M., Nowels K., et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88 (2003) 1880-1888
10. Arturi F., Russo D., Schlumberger M., et al. Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83 (1998) 2493-2496
11. Scipioni A., Ferretti E., Soda G., et al. hNIS protein in thyroid: the iodine supply influences its expression and localization. Thyroid 17 (2007) 613-618
12. Castro M.R., Bergert E.R., Beito T.G., et al. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. J Clin Endocrinol Metab 84 (1999) 2957-2962
13. Dall'Era M.A., Cooperberg M.R., Chan J.M., et al. Active surveillance for early stage prostate cancer: review of the literature. Cancer 112 (2008) 1650-1659
14. Zippe C.D., and Kedia A.W. Locally invasive prostate cancer: an evolving concept of advanced disease. In: Klein E.A. (Ed). Management of Prostate Cancer (2000), Humana press, Totowa, NJ 223-243
15. Riesco-Eizaguirre G., and Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155 (2006) 495-512
16. Spitzweg C., Zhang S., Bergert E.R., et al. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res 59 (1999) 2136-2141
17. Spitzweg C., O'Connor M.K., Bergert E.R., et al. Treatment of prostate cancer by radioiodide therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60 (2000) 6526-6530
18. Spitzweg C., Dietz A.B., O'Connor M.K., et al. In vivo sodium iodide symporter gene therapy of in prostate cancer. Gene Ther 8 (2001) 1524-1531
19. 2PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res 63 (2003) 7840-7844
20. Foley R., Lawyer M., and Hollywood D. Gene-based therapy in prostate cancer. Lancet Oncol 5 (2004) 469-479
21. Haberkorn U., Kinscherf R., Kissel M., et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther 10 (2003) 774-780
22. Huang D., Casale G.P., Tian J., et al. Quantitative fluorescence imaging analysis for cancer biomarker discover application to beta-catenin in archived prostate specimens. Cancer Epidemiol Biomarkers Prev 16 (2007) 1371-1381
23. Trouttet-Masson S., Selmi-Ruby S., Bernier-Valentin F., et al. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am J Pathol 165 (2004) 25-34
24. Sodrè A.K., Rubio I.G., Galrão A.L., et al. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increate intracellular protein staining. J Clin Endocrinol Metab 93 (2008) 4141-4145
25. Kogai T., Taki K., and Brent G.A. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 13 (2006) 797-826
26. Schlumberger M., Lacroix L., Russo D., et al. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nat Clin Pract Endocrinol Metab 3 (2007) 263-269
27. Barton K.N., Stricker H., Brown S.L., et al. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol Ther 16 (2008) 1761-1769
28. 131 therapy for thyroid cancer. Clin Endocrinol 56 (2002) 755-758
29. 131 therapy for hyperthyroidism. Clin Endocrinol 65 (2006) 446-452
30. Sawka A.M., Lea J., Alshehri B., et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol 68 (2008) 610-617